Antiangiogenic treatment with endostatin inhibits progression of AML in vivo.

Autor: Schuch, G.1 schuch@uke.uni-hamburg.de, Oliveira-Ferrer, L.2, Loges, S.1, Laack, E.1, Bokemeyer, C.1, Hossfeld, D. K.1, Fiedler, W.1, Ergun, S.2
Zdroj: Leukemia (08876924). Aug2005, Vol. 19 Issue 8, p1312-1317. 6p.
Databáze: Academic Search Ultimate